Misconceptions about HRT & What Your Doctor May Not Have Told You
In 2002, the Women's Health Initiative published findings that changed how a generation of clinicians talked about hormone replacement therapy.
The conversation that followed was not wrong, exactly. It was incomplete. And the incompleteness was costly: for the women who stopped HRT abruptly, for the women who were never offered it, and for the clinical culture that defaulted to caution in ways that had their own risk profile, even if that risk was harder to name.
In the years since, the evidence has been substantially reanalysed, recontextualised, and extended. The picture that has emerged is more nuanced and, for most women, more favourable than the original framing suggested.
Three misconceptions in particular continue to shape conversations that deserve to be updated.
MISCONCEPTION 1: "HRT causes breast cancer."
What the updated evidence shows
The WHI used oral conjugated equine estrogen combined with medroxyprogesterone acetate, a synthetic progestin, in women who were on average 63 years old and more than ten years past menopause. The breast cancer signal observed was small, was not seen in the estrogen-only arm, and has not been consistently replicated in studies using body-identical micronised progesterone.
The 2019 collaborative reanalysis in The Lancet pooled data from 58 studies but drew significant methodological criticism for conflating very different hormone types, routes, and durations. Body-identical transdermal estradiol with micronised progesterone carries a different risk profile from synthetic oral combinations. Most women are not told this distinction exists.
MISCONCEPTION 2: "HRT is only for managing symptoms. Once symptoms resolve, you should stop."
What the updated evidence shows
This framing treats HRT as a symptom management tool when the evidence now supports broader systemic benefits when it is initiated in the right window. The timing hypothesis, supported by multiple analyses including the KEEPS and ELITE trials, shows that HRT started within ten years of menopause onset is associated with reduced cardiovascular disease risk, improved bone mineral density, and emerging cognitive protection.
These are not symptom benefits. They are long-term biological outcomes. Stopping HRT at symptom resolution may mean leaving those protective effects behind during the window when they are most active.
MISCONCEPTION 3: "All HRT is essentially the same."
What the updated evidence shows
Route of delivery, hormone type, and formulation are not interchangeable. Transdermal estradiol bypasses first-pass liver metabolism, does not raise clotting risk, does not elevate SHBG, and does not alter bile composition the way oral estrogen does. Micronised progesterone has a meaningfully different safety and tolerability profile from synthetic progestins.
The distinction between body-identical and synthetic hormones matters clinically. The evidence supporting body-identical transdermal therapy is substantially more favourable than the original WHI data, which used neither.
None of this means HRT is right for every woman. There are genuine contraindications. There are individual risk profiles that change the calculation. And the decision belongs between a woman and a clinician who knows her full history and is current with the evidence.
What it does mean is that the conversation most women are having about HRT is still being shaped by a study conducted in a different population, with different hormones, at a different stage of the menopausal transition. An updated conversation, grounded in the evidence as it now stands, leads somewhere different for most women than the standard clinical script suggests.
You deserve that updated conversation.
““Women deserve a conversation about HRT that reflects the evidence as it actually stands today, not as it was understood in 2002. For most women, that updated conversation leads somewhere quite different from the standard clinical script.””
Questions about how Chinese medicine fits your situation?
A consultation allows us to review your current medications, health history and symptom picture to discuss what a complementary approach might look like for you specifically.